"Designing Growth Strategies is in our DNA"

U.S. Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Industry Analysis, By Product Type (Systems and Consumables {Dialysates, Replacement Solutions, Filters, Catheters, and Others}), By Modality (Slow Continuous Ultra Filtration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Hemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF}), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI109172

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Acute Kidney Failure in the U.S.
    2. Reimbursement Scenario in the U.S.
    3. New Product Launches, By Key Players
    4. Key Industry Developments Mergers, Acquisitions, and Partnerships
    5. Impact of Covid-19 on the Market
  5. U.S. Continuous Renal Replacement Therapy (CRRT) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Systems
      2. Consumables
        1. Dialysates
        2. Replacement Solutions
        3. Filters
        4. Catheters
        5. Others
    2. Market Analysis, Insights and Forecast – By Modality
      1. Slow Continuous Ultra Filtration (SCUF)
      2. Continuous Venovenous Hemofiltration (CVVH)
      3. Continuous Venovenous Hemodialysis (CVVHD)
      4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles for Selected Leading Players
      1. Baxter
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. B. Braun SE
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Fresenius Medical Care AG & Co. KgaA
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Medtronic
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. BD
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Medical Components Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Asahi Kasei Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Million) Forecast, by Product Type, 2019–2032

Table 02: U.S. Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Million) Forecast, by Consumables, 2019–2032

Table 03: U.S. Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Million) Forecast, by Modality, 2019–2032

Figure 01: U.S. Continuous Renal Replacement Therapy (CRRT) Market Revenue Breakdown (USD million, %) by Product Type, 2022 & 2032

Figure 02: U.S. Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2022 & 2032

Figure 03: U.S. Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2022 & 2032

Figure 04: U.S. Continuous Renal Replacement Therapy (CRRT) Market Share (%), By Company, 2023

  • 2019-2032
  • 2023
  • 2019-2022
  • 60
Consulting Services
    How will you benefit from our consulting services ?